Search This Blog

Wednesday, August 14, 2019

Y-mAbs Therapeutics EPS misses by $0.04

Y-mAbs Therapeutics (NASDAQ:YMAB): Q2 GAAP EPS of -$0.53 misses by $0.04.
Cash and equivalents of $120.16M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)